Sepsis Multiomic Analysis & Risk sTratification in China

Recruiting Observational Study
Sepsis
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
1,400 (estimated)
Sponsor
Yuebei People's Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection, and delayed diagnosis remains a major driver of mortality, while traditional biomarkers (PCT, CRP, lactate) have limited early sensitivity and timeliness. This prospective, single-center, observational cohort study at Yuebei People's Hospital will enroll approximately 1400 ICU patients (1000 with se…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria - Sepsis Group: * Age ≥ 18 years * Meets the Sepsis-3 diagnostic criteria: confirmed or suspected infection with an increase in SOFA score of ≥ 2 points from baseline * Develops sepsis within 72 hours of ICU admission * Voluntarily signs the informed consent form (or signed by th…
Contacts

Principal Investigator

8613923034950

zhaopingsen01@163.com

CONTACT